CardioPhyt™ - References

I Product Info I Ingredients I Recommended Use I Clinical Trials I Research Brief I References

cardiophlg

 

 

Order this item

Low USA domestic & international shipping

Indication: coronary  and peripheral circulation impairment; impaired myocardial contractility and heart rhythm; high blood pressure; high cholesterol level; vitamin, mineral and microelement deficiency; physical and nervous overload.

Main Actions:improves blood supply to heart and brain, helps maintain healthy cholesterol levels, strengthens blood vessel walls, lowers blood pressure, normalizes the heart rhythm, heart muscle energizer.

Ingredients (per 1 capsule):

Vitamin A (as beta carotene and natural mixed carotenoids (beta-carotene, alpha-carotene, zeaxanthin, cryptoxanthin & lutein)- 2500 IU, Vitamin C (as ascorbyl palmitate) - 110 mg, Vitamin E (as dl-alpha-tocopheryl acetate) - 26 IU, Vitamin B3 (as niacin and niacinamide) - 4 mg, Folic acid - 40 mcg, Vitamin B12 (as cyanocobalamin) - 2 mcg, Magnesium (as magnesium amino acid chelate) - 31.7 mg, Zinc (as zinc amino acid chelate) - 2 mg, Selenium (as selenium amino acid chelate) - 12 mcg, Potassium (as potassium citrate) - 20 mg, Proprietary Blend - 100 mg: Coenzyme Q10, L-Carnitine, Red wine grape extract, Ginkgo biloba (Ginkgo biloba)  leaf extract (50:1) (24 % ginkgo flavone glycosides and 6 % terpene lactones), Odor-controlled garlic (Allium sativum) extract (10,000 ppm allicin), Hawthorn (Crataegus spp) berry concentrate.

 

 

CardioPhyt™ - References:

 

  1. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, September 2002. NIH Publication No. 02-5215.
  2. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7:113-74.
  3. Brown WV. Niacin for lipid disorders. Postgrad Med 1995;98:185–93 [review].
  4. Guyton JR. Effect of niacin on atherosclerotic cardiovascular disease. Am J Cardiol 1998;82(12A):18U–23U [review].
  5. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
  6. Bottiglieri T, Reynolds EH, Laundy M. Folate in CSF and age. J Neurol Neurosurg Psychiatry 2000; 69: 562
  7. Homocysteine Lowering Trialists‘ Collaboration: Lowering blood homocysteine with folic acid based supplements: metaanalysis of randomised trials. BMJ 1998;316:894-8.
  8. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press. Washington, DC, 1999.
  9. Clostre F. From the body to the cell membranes: the different levels of pharmacological action of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic.Fünfgeld EW, ed. Berlin: Springer-Verlag, 1988, 180-98.
  10. Jialal I and Fuller CJ. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11 Suppl G:97G-103G.
  11. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9
  12. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9.
  13. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001;161:695-700.
  14. Pittler MH , Schmidt K, Ernst E. – Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth , 25 Victoria Park Road , Exeter EX2 4NT, United Kingdom. Am J Med. 2003 Jun 1 ; 114 (8): 665-74